Participation in clinical trial research is essential to continued improvement in cancer care. Yet, fewer than 10% of U.S. adults enroll in trials. A recent US OncologyÃ¢ï¿½ï¿½sponsored survey found that most
oncologists remain optimistic about the future of clinical trial research. We discuss obstacles to clinical trial enrollment with Nicholas Vogelzang, MD, and Matthew Galsky, MD, of the Comprehensive CancerCenters of Nevada.
While clinical studies and personalized medicine are clearly the future of cancer treatment, barriers to patient participation come from several directions, including patients, physicians, and the insurance industry. A US Oncologyâ€“sponsored survey of oncologists and clinical research professionals found them to be highly optimistic about the future of clinical trials in advancing personalized medicine, despite concerns about the various hurdles. The national survey of 299 oncology and clinical research professionals determined that 58% of respondents were optimistic about trials, while only 25% were ambivalent or unsure.